Skip to content Skip to footer
Atovaquone & Proguanil: Benefits, Reviews, Info, Side Effects!
Rx Details
Atovaquone & Proguanil
Malarone, Malanil
Atovaquone & Proguanil
Prescription
Antimalarial
Drugs
Prescription Only
malaria prevention, malaria treatment, well-tolerated, convenient dosing, effective against Plasmodium falciparum, suitable for travelers, short treatment course
Abdominal Pain, Cough, Diarrhea, Dizziness, Fever, Headache, Insomnia, Loss Of Appetite, Mouth Sores, Nausea, Rash, Vomiting
Atovaquone and proguanil is a combination medication commonly used for the prevention and treatment of malaria. The average dosage can vary based on the purpose (prevention or treatment), the patient’s age, weight, and specific health conditions. Here are some general guidelines: 1. **For Malaria Prevention:** – **Adults:** One tablet (250 mg atovaquone/100 mg proguanil) taken once daily, starting 1-2 days before entering a malaria-endemic area, continuing daily during the stay, and for 7 days after leaving the area. – **Children:** Dosage is based on weight. The pediatric tablets contain 62.5 mg atovaquone and 25 mg proguanil. The specific dosage should be determined by a healthcare provider. 2. **For Malaria Treatment:** – **Adults:** Four tablets (totaling 1,000 mg atovaquone/400 mg proguanil) taken as a single dose daily for three consecutive days. – **Children:** Again, the dosage is based on weight and should be determined by a healthcare provider. It’s important to follow the specific instructions provided by a healthcare professional, as they can tailor the dosage to individual needs and circumstances. Always consult a healthcare provider for the most accurate and personalized dosage information.
Malaria prevention, malaria treatment
Generally well-tolerated, with rare serious side effects.
No Interactions Reported
$20 – $50
$69.99

A Synopsis of

Atovaquone & Proguanil

Atovaquone and Proguanil is a combination medication used for the prevention and treatment of malaria. Malaria is a serious and potentially life-threatening disease caused by parasites that are transmitted through the bites of infected mosquitoes. This medication works by interfering with the growth and reproduction of the malaria parasites in the body.

Atovaquone and Proguanil is typically taken once a day, starting one to two days before entering a malaria-endemic area and continuing for seven days after leaving the area. It is important to take this medication exactly as prescribed by your healthcare provider to ensure its effectiveness.

Common side effects of Atovaquone and Proguanil may include stomach upset, headache, and dizziness. It is important to notify your healthcare provider if you experience any severe or persistent side effects while taking this medication.

It is important to note that Atovaquone and Proguanil is not suitable for everyone. Before starting this medication, inform your healthcare provider about any medical conditions you have, especially liver or kidney disease, as well as any other medications or supplements you are currently taking.

If you are pregnant or breastfeeding, it is important to discuss the risks and benefits of taking Atovaquone and Proguanil with your healthcare provider before starting treatment.

Overall, Atovaquone and Proguanil is a valuable medication for the prevention and treatment of malaria. By following your healthcare provider’s instructions and taking this medication as directed, you can help protect yourself from this potentially dangerous disease.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

0
Would love your thoughts, please comment.x
()
x
en_USEN